Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.

Kojima, S; Chiyomaru, T; Kawakami, K; Yoshino, H; Enokida, H; Nohata, N; Fuse, M; Ichikawa, T; Naya, Y; Nakagawa, M; Seki, N

Kojima, S; Chiyomaru, T; Kawakami, K; Yoshino, H; Enokida, H; Nohata, N; Fuse, M; Ichikawa, T; Naya, Y; Nakagawa, M; Seki, N.

Affiliation

Kojima S; Department of Urology, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara, Chiba 299-0111, Japan.

Br J Cancer ; 106(2): 405-13, 2012 Jan 17.

Article in En | MEDLINE | ID: mdl-22068816

Subject(s)

Genes, Tumor Suppressor; MicroRNAs/genetics; Prostatic Neoplasms/genetics; Purine-Nucleoside Phosphorylase/metabolism; Aged; Aged, 80 and over; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms/enzymology; Prostatic Neoplasms/pathology; Purine-Nucleoside Phosphorylase/genetics; RNA Processing, Post-Transcriptional; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Genes, Tumor Suppressor / Purine-Nucleoside Phosphorylase / MicroRNAs Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google